Title: From Coverage to Data Treatment: Emerging Challenges in Metabolomics

Serge Rudaz is a Full Professor at the University of Geneva, leading the Biomedical and Metabolomic Analysis (BMA) research group. He serves as Vice-President of the School of Pharmaceutical Sciences and is a member of the Management Board of the Swiss Centre for Applied Human Toxicology (SCAHT) Foundation. Prof. Rudaz participates in numerous Scientific Boards such as the Swiss Metabolomics Society (SMS), the Competence Center in Chemical and Toxicological Analysis (ccCTA), the Academic Society of Geneva (SACAD). His research interests encompass ultra-high-performance liquid chromatography (UHPLC) and capillary electrophoresis (CE) coupled with mass spectrometry (MS), advancements in sample preparation, analysis of pharmaceuticals and falsified medicines, biological matrices, as well as clinical and preclinical studies, including metabolism, toxicological analysis, and metabolomics. Prof. Rudaz has authored or co-authored over 25 book chapters and more than 370 peer-reviewed papers, achieving an H-index of 79 on Google Scholar.Throughout his career, he has chaired or co-chaired several national and international congresses, such as Chimiométrie 2015, SEP 2017, MSB 2020, and PBA 2024. His research group has also focused on developing chemometric approaches dedicated to the analysis of data produced by MS couplings. Aspects of dimensionality reduction and multi-table analysis are addressed through collaborative projects in the fields of toxicology, biology, biochemistry, and pharmacology.